Health Condition 1: C711- Malignant neoplasm of frontal lobe Health Condition 2: C711- Malignant neoplasm of frontal lobe Health Condition 3: null- Patients who are undergoing elective craniotomy and excision for supratentorial tumors at the Institute
Conditions
Interventions
Intervention1: Dexmedetomidine: Dexmedetomidine is a widely used anesthetic adjunct in several types of neurosurgeries. Its use is rapidly increasing. It will be given as a bolus dose of 1 ugm/kg over
Sponsors
All India Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: American Society of Anesthesiologists Class 1, Patients undergoing elective craniotomy and excision for supratentorial tumors at AIIMS
Exclusion criteria
Exclusion criteria: Patients with history of any neurological or vascular disease, syncope, dizziness, seizure or loss of consciousness, anticipated difficult airway, previous intracranial surgery, presence of impaired cerebral autoregulation and those unable or unwilling to give a written informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect of dexmedetomidine on dynamic cerebral autoregulation in patients with supratentorial tumors under sevoflurane anesthesia.Timepoint: During the study period (2 years) | — |
Secondary
| Measure | Time frame |
|---|---|
| To note any side effect or complication with the use of dexmedetomidine in patients undergoing supratentorial tumour surgery under sevoflurane anesthesiaTimepoint: During the study period (two years) | — |
Countries
India
Contacts
Public ContactDr Girija Prasad Rath
All India Institute of Medical Sciences
Outcome results
None listed